U.S. Biomea Fusion, Enphase Energy, Perion Network
June 11 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Biomea Fusion, Enphase Energy and Perion Network, on Tuesday.
HIGHLIGHTS
* Biomea Fusion Inc BMEA.O: Truist Securities cuts to hold from buy |
* Cleveland-Cliffs Inc CLF.N: JP Morgan cuts to neutral from overweight |
* Enphase Energy Inc ENPH.O: HSBC raises to buy from hold |
* Perion Network Ltd PERI.O: Needham cuts to hold from buy |
* TD Synnex Corp SNX.N: RBC raises target price to $135 from $118 |
Following is a summary of research actions on US companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Addus Homecare Corp ADUS.O: Raymond James raises target price to $125 from $115 |
* Aflac Inc AFL.N: Raymond James raises target price to $94 from $88 |
* AIG AIG.N: BofA Global Research raises price objective to $84 from $82 |
* Alphabet Inc GOOGL.O: Evercore ISI raises target price to $225 from $220 |
* Apple Inc AAPL.O: D.A. Davidson raises target price to $230 from $200 |
* Apple Inc AAPL.O: D.A. Davidson raises to buy from neutral |
* AZZ Inc AZZ.N: Noble Capital raises to outperform |
* BAT BTI.N: Morgan Stanley cuts target price to $34 from $35.5 |
* Biomea Fusion Inc BMEA.O: Truist Securities cuts to hold from buy |
* Children's Place Inc PLCE.O: UBS cuts target price to $12 from $24 |
* Cleveland-Cliffs Inc CLF.N: JP Morgan cuts to neutral from overweight |
* Cleveland-Cliffs Inc CLF.N: JP Morgan cuts to target price to $17 from $23 |
* Comstock Resources Inc CRK.N: Gerdes Energy Research cuts to neutral from buy |
* Confluent Inc CFLT.O: Evercore ISI initiates coverage with outperform rating; PT $35 |
* Corbus Pharmaceuticals Holdings Inc CRBP.O: RBC raises target price to $82 from $77 |
* Corecivic Inc CXW.N: Wedbush cuts to neutral from outperform; cuts PT to $14 from $19 |
* Darden Restaurants Inc DRI.N: Wedbush cuts target price to $170 from $181 |
* Dave & Buster's Entertainment Inc PLAY.O: Truist Securities cuts PT to $67 from $78 |
* Eli Lilly LLY.N: Jefferies raises target price to $994 from $957 |
* Enliven Therapeutics Inc ELVN.O: Baird initiates coverage with outperform rating; PT $32 |
* Enphase Energy Inc ENPH.O: HSBC raises target price to $166 from $104 |
* Enphase Energy Inc ENPH.O: HSBC raises to buy from hold |
* Factset Research Systems Inc FDS.N: UBS cuts target price to $455 from $480 |
* Ford Motor Co F.N: HSBC raises target price to $13 from $11.3 |
* Freshpet Inc FRPT.O: Benchmark raises target price to $150 |
* FTAI Aviation Ltd FTAI.O: Citigroup raises target price to $99 from $81 |
* Fuelcell Energy Inc FCEL.O: Jefferies cuts target price to $1.11 from $1.25 |
* GE Vernova GEV.N: Citigroup initiates coverage with neutral rating; PT $183 |
* General Motors Co GM.N: HSBC raises target price to $56 from $48 |
* Geron Corp GERN.O: Barclays initiates coverage with overweight rating and PT $9 |
* Gladstone Land LAND.O: Alliance Global Partners initiates coverage with buy rating; PT $16 |
* Goosehead Insurance Inc GSHD.O: BofA Global Research raises PT to $37 from $35 |
* Illumina Inc ILMN.O: Evercore ISI cuts target price to $175 from $195 |
* KKR & Co Inc KKR.N: Deutsche Bank raises target price to $129 from $120 |
* Longboard Pharmaceuticals Inc LBPH.O: B. Riley raises target price to $36 from $30 |
* Manpowergroup MAN.N: Exane BNP Paribas raises to outperform from underperform |
* Marriott International Inc MAR.O: UBS raises target price to $267 from $259 |
* Micron Technology Inc MU.O: Bernstein raises target price to $140 from $105 |
* Nucor Corp NUE.N: JP Morgan cuts target price to $180 from $190 |
* Nvidia Corp NVDA.O: Evercore ISI adjusts PT to $131 from $1310 to reflect 10-for-1 stock split |
* Nvidia Corp NVDA.O: Oppenheimer adjusts PT to $150 from $110 to reflect 10-for-1 stock split |
* Oscar Health Inc OSCR.N: Raymond James raises PT to $30 from $25 |
* Par Technology Corp PAR.N: Benchmark raises PT to $61 from $59 |
* Par Technology Corp PAR.N: Needham raises PT to $57 from $53 |
* Perion Network Ltd PERI.O: Needham cuts to hold from buy |
* Powerschool Holdings PWSC.N: Raymond James cuts to market perform from outperform |
* Prokidney Corp PROK.O: Jefferies cuts target price to $6 from $15 |
* Redwood Trust RWT.N: Jonestrading initiates coverage with buy rating; PT $7.25 |
* RLJ Lodging Trust RLJ.N: Baird cuts target price to $12 from $13 |
* Robert Half RHI.N: Exane BNP Paribas raises to outperform from underperform |
* Skye Bioscience Inc SKYE.O: Oppenheimer cuts target price to $21 from $25 |
* Staar Surgical Co STAA.O: BTIG raises to buy from neutral |
* Targa Resources Corp TRGP.N: UBS raises target price to $147 from $116 |
* TD Synnex Corp SNX.N: RBC raises target price to $135 from $118 |
* Vertex Pharmaceuticals Inc VRTX.O: RBC cuts PT to $421 from $424 |
* Walmart WMT.N: HSBC raises target price to $81 from $70 |
* Western Digital Corp WDC.O: Susquehanna raises target price to $88 from $80 |
* Yext Inc YEXT.N: D.A. Davidson cuts target price to $5.5 from $7.25 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
